256 related articles for article (PubMed ID: 26981734)
1. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.
Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI
JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734
[TBL] [Abstract][Full Text] [Related]
2. A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery.
Basu P; Goldenberg A; Cowan N; Eilers R; Hau J; Jiang SIB
J Am Acad Dermatol; 2019 Jun; 80(6):1594-1601. PubMed ID: 30502411
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors.
Goldenberg A; Ortiz A; Kim SS; Jiang SB
J Am Acad Dermatol; 2015 Jul; 73(1):120-6. PubMed ID: 25840729
[TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
6. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter?
Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH
Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
8. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
10. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
11. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
12. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
14. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery.
Batra RS; Kelley LC
Arch Dermatol; 2002 Aug; 138(8):1043-51. PubMed ID: 12164742
[TBL] [Abstract][Full Text] [Related]
15. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
16. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
17. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Analysis of Complication Rates in Mohs Micrographic Surgery Patients With Clinically Large Tumors and Tumors With Aggressive Subclinical Extension.
Cowan N; Goldenberg A; Basu P; Eilers R; Hau J; I Brian Jiang S
J Drugs Dermatol; 2018 May; 17(5):511-515. PubMed ID: 29742181
[TBL] [Abstract][Full Text] [Related]
19. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Internal Malignancy Following a Prior Diagnosis of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients.
Gal N; Didkovsky E; Hodak E; Davidovici BB
Isr Med Assoc J; 2022 Apr; 24(4):219-224. PubMed ID: 35415979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]